Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-19

Clinical Trial Update: Dexmedetomidine and Postoperative Cognitive Dysfunction (POCD) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on dexmedetomidine for postoperative cognitive dysfunction and pain; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Udayana University | Conditions: Postoperative Cognitive Dysfunction, Postoperative Pain | Phase 4 | Status: COMPLETED